CoChat

Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy

Open access
von Moos, Seraina, Johansen, Pål, Tay, Fabian, Graf, Nicole, Kündig, Thomas M., Senti, Gabriela · 2014 · Journal of Allergy and Clinical Immunology
Cited by 45

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Development of cutaneous delivery systems enabling needle-free and self-administrable vaccine administration is one important approach to improve global health care. Passing the epidermal barrier structures is a challenge to the successful delivery of antigens: (1) the stratum corneum, composed of cornified keratinocytes surrounded by lipids, and (2) tight junctions in the stratum granulosum, providing ion and size selectivity.1De Benedetto A. Kubo A. Beck L.A. Skin barrier disruption: a requirement for allergen sensitization?.J Invest Dermatol. 2012; 132: 949-963Crossref PubMed Scopus (212) Google Scholar Langerhans cells (LCs), able to capture antigen and induce adaptive immune responses, are found below these 2 barrier structures.1De Benedetto A. Kubo A. Beck L.A. Skin barrier disruption: a requirement for allergen sensitization?.J Invest Dermatol. 2012; 132: 949-963Crossref PubMed Scopus (212) Google Scholar For efficient induction of immune responses, LCs need to be activated to elongate their dendrites through the tight junctions. Whether physical epidermal barrier disruption is necessary for efficient antigen capture is still a matter of debate. Recently, a transcutaneous vaccine delivery platform was developed by Intercell and approved for prophylactic vaccination against Japanese encephalitis. For efficient immunization, an abrasive skin preparation system is used before vaccine delivery, based on trials showing direct correlation between degree of skin disruption and magnitude of antibody responses.2Frerichs D.M. Ellingsworth L.R. Frech S.A. Flyer D.C. Villar C.P. Yu J. et al.Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch.Vaccine. 2008; 26: 2782-2787Crossref PubMed Scopus (51) Google Scholar, 3Glenn G.M. Villar C.P. Flyer D.C. Bourgeois A.L. McKenzie R. Lavker R.M. et al.Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.Infect Immun. 2007; 75: 2163-2170Crossref PubMed Scopus (66) Google Scholar Besides facilitating skin permeability, mechanical barrier-disruption also activates and polarizes LCs through the release of cytokines acting as adjuvant.4Nickoloff B.J. Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin.J Am Acad Dermatol. 1994; 30: 535-546Abstract Full Text PDF PubMed Scopus (425) Google Scholar We recently demonstrated the efficacy of epicutaneous immunization in allergy immunotherapy5Senti G. von Moos S. Tay F. Graf N. Sonderegger T. Johansen P. et al.Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study.J Allergy Clin Immunol. 2012; 129: 128-135Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 6Senti G. Graf N. Haug S. Ruedi N. von Moos S. Sonderegger T. et al.Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.J Allergy Clin Immunol. 2009; 124: 997-1002Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar using adhesive tape-stripping for skin preparation and found higher allergen doses showing higher clinical efficacy.5Senti G. von Moos S. Tay F. Graf N. Sonderegger T. Johansen P. et al.Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study.J Allergy Clin Immunol. 2012; 129: 128-135Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar We therefore aimed to enhance allergen delivery by using abrasion rather than tape-stripping for skin preparation as shown for other transcutaneous vaccines.3Glenn G.M. Villar C.P. Flyer D.C. Bourgeois A.L. McKenzie R. Lavker R.M. et al.Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum.Infect Immun. 2007; 75: 2163-2170Crossref PubMed Scopus (66) Google Scholar However, enhanced skin disruption may represent a safety risk in allergic individuals. A detailed methodology is given in this article's Online Repository at www.jacionline.org. Briefly, a total of 98 grass-pollen–allergic patients were included and randomly assigned to receive placebo epicutaneous allergen-specific immunotherapy (EPIT) (1.5 mL petrolatum) or allergen EPIT (1.5 mL allergen-extract, Stallergènes, 200 IR/mL). Before application of the first patch, 2 skin-preparation procedures were tested: abrasion with a foot-file (52 patients: 26 placebo and 26 allergen) or adhesive tape-stripping (45 patients: 21 placebo and 24 allergen) (see Fig E1 in this article's Online Repository at www.jacionline.org). The degree of skin disruption was measured by transepidermal water loss (TEWL) before and after skin preparation. For safety, patients were observed for 30 minutes and local

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2014.07.037

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 45

Metadata

Authors
von Moos, S., Johansen, P., Tay, F., Graf, N., Kündig, T. M., & Senti, G.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2014-10
Volume
134
Issue
4
Pages
965-967.e4
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2131276393
Cited by
45
References
4
FWCI
4.47
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.